Global Blood raises $120M in follow-on

Global Blood Therapeutics Inc. (NASDAQ:GBT) raised $120 million through the sale of 6.4 million shares at $18.75 in a bumped-up follow-on. JPMorgan, Morgan Stanley, Cowen and Wedbush PacGrow are underwriters.

The company submitted a preliminary prospectus to raise $100 million in a regulatory document filed after market close on June 10, when its share price was $24.15. Global Blood proposed to raise $100 million in a company announcement before market hours June 20, when its shares were worth $17.83. ...